| View |
|
DRP-12738-08
|
Telmisartan + Amlodipine (as besilate)
|
Corvita 40/5
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
30 September 2027
|
| View |
|
DRP-12759-02
|
Pregabalin + Methylcobalamin
|
Pregmecom
|
75 mg / 750 mcg
|
Capsule
|
Antiepileptic / Vitamin (Cyanocobalamin analogue) combination
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
03 October 2027
|
| View |
|
DRP-12849-01
|
Zoledronic acid (as monohydrate)
|
Ledrocid
|
4 mg
|
Lyophilized Powder for Solution for Infusion (I.V.)
|
Bisphosphonate
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
14 October 2027
|
| View |
|
DRP-12886-02
|
Bupivacaine hydrochloride
|
Bupibaric
|
5 mg/mL (0.5% w/v)
|
Solution for Injection (for Peripheral Nerve Block, Caudal Block, and Lumbar Epidural Block)
|
Local Anesthetic (Amide)
|
HBM Pharma S.R.O.
|
Slovak Republic
|
CLIDP Conversion
|
06 May 2024
|
25 October 2027
|
| View |
|
DRP-13127-08
|
Ketoanalogues + Essential Amino Acids
|
Ketodix
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 May 2024
|
05 December 2027
|
| View |
|
DRP-13280-01
|
Octreotide (as acetate)
|
Ocreon 100
|
100 mcg/ mL
|
Solution for Injection for S.C./ I.V. Infusion
|
Hypothalamic Hormone (Somatostatin and Analogue)
|
United Biotech Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
18 January 2028
|
| View |
|
DRP-13361-01
|
Meclizine Hydrochloride
|
Eramel
|
12.5 mg
|
Chewable Tablet (Orange Flavor)
|
Anti-emetic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
06 May 2024
|
06 February 2028
|
| View |
|
DRP-13523-01
|
Losartan potassium + Amlodipine (as besilate)
|
Syntria
|
50 mg/5 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)/Angiotensin II Receptor Blocker (ARB)
|
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
|
India
|
CLIDP Conversion
|
06 May 2024
|
03 March 2028
|
| View |
|
DRP-13523-02
|
Losartan potassium + Amlodipine (as besilate)
|
Colixtan
|
50 mg / 5 mg
|
Film-Coated Tablet
|
Calcium channel Blocker (Dihydropyridine Derivative) / Angiotensin II Receptor Blocker (ARB)
|
Unison Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 May 2024
|
03 March 2028
|
| View |
|
DRP-13647-01
|
Pregabalin
|
Prebamin 75
|
75 mg
|
Capsule
|
Antiepileptic
|
Sunglow Lifesciences Private Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
22 March 2028
|
| View |
|
DRP-13712-06
|
Moxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium)
|
IKSHADEX
|
5 mg/1 mg per mL (0.5% w/v / 0.1% w/v)
|
Ophthalmic Solution
|
Anti-infective (Fluoroquinolone) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
30 March 2028
|
| View |
|
DRP-13733-01
|
Meropenem
|
Meroparvin
|
1 g
|
Powder for Injection
|
Antibacterial (Carbapenem)
|
Mason Pharma
|
India
|
CLIDP Conversion
|
10 May 2024
|
03 April 2028
|
| View |
|
DRP-13814
|
Salbutamol (as Sulfate)
|
Amoltex
|
2 mg
|
Tablet
|
Antiasthma
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
10 May 2024
|
19 August 2029
|
| View |
|
DRP-13838-01
|
Pregabalin
|
Prebamin 150
|
150 mg
|
Capsule
|
Antiepileptic
|
Sunglow Lifesciences Private Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
27 April 2028
|
| View |
|
DRP-13867-01
|
Levetiracetam
|
Sezuvin
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (I.V.)
|
Antiepileptic
|
Mason Pharma
|
India
|
CLIDP Conversion
|
07 May 2024
|
05 May 2028
|
| View |
|
DRP-13880-02
|
Acetylcysteine
|
Pulmocare 200
|
200 mg
|
Granules for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
12 May 2028
|
| View |
|
DRP-13927-01
|
Bortezomib
|
Zomicor
|
3.5 mg
|
Lyophilized Powder for Solution for Injection (I.V./S.C.)
|
Antineoplastic Agent (Proteasome Inhibitor)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
18 May 2028
|
| View |
|
DRP-14066-02
|
Vildagliptin
|
Vilaptin
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Lee Pharma Limited
|
India
|
CLIDP Conversion
|
06 May 2024
|
13 June 2028
|
| View |
|
DRP-14138-03
|
Azithromycin (as dihydrate)
|
Azcore
|
200 mg/ 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Macrolide)
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
10 May 2024
|
30 June 2028
|
| View |
|
DRP-14208-01
|
Pantoprazole (as sodium)
|
Gastrozen
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 May 2024
|
21 July 2028
|